These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1196541)

  • 21. [Research on thrombogenesis in chronic obliterating arteriopathies of the extremities].
    Stăncioiu N; Scrobohaci ML
    Med Interna (Bucur); 1973 Aug; 25(8):963-79. PubMed ID: 4793915
    [No Abstract]   [Full Text] [Related]  

  • 22. [Medical therapy of obliterating arteriopathies].
    Schwarz D
    Minerva Med; 1969 Oct; 60(87):4335-44. PubMed ID: 4242895
    [No Abstract]   [Full Text] [Related]  

  • 23. [Differential arteriographic diagnosis of chronic obliterating arteriopathies].
    Vidal-Barraquer FA
    Angiologia; 1974; 26(2):52-6. PubMed ID: 4451289
    [No Abstract]   [Full Text] [Related]  

  • 24. High prevalence of peripheral arterial disease and low treatment rates in elderly primary care patients with diabetes.
    Lange S; Diehm C; Darius H; Haberl R; Allenberg JR; Pittrow D; Schuster A; von Stritzky B; Tepohl G; Trampisch HJ
    Exp Clin Endocrinol Diabetes; 2004 Nov; 112(10):566-73. PubMed ID: 15578331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Late postoperative evolution of juvenile arteritis].
    Jausseran JM; Reggi M; Bergeron P; Lemière JM; Courbier R
    J Mal Vasc; 1985; 10(4):291-5. PubMed ID: 4093716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Current diagnostic and therapeutic trends in obliterating arteriopathies: oscillometry and Doppler examination].
    De Martiis M; Assogna G; D'Ottavi O; D'Ottavi R; Fontana M
    Clin Ter; 1980 Oct; 95(2):115-25. PubMed ID: 7471651
    [No Abstract]   [Full Text] [Related]  

  • 27. Ischemic neuropathy.
    Cahill BE; Kerstein MD
    Surg Gynecol Obstet; 1987 Nov; 165(5):469-74. PubMed ID: 2823402
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Further studies of the incidence of coronary cardiopathy in subjects with peripheral arteriosclerotic obliterating arteriopathy. Clinico-statistical investigations of 1434 cases].
    Meciani L; Ricci G; Boeri S; Sabatini G; Biasi G; Biglioli P
    Minerva Cardioangiol; 1971 Mar; 19(3):147-51. PubMed ID: 5553463
    [No Abstract]   [Full Text] [Related]  

  • 29. [Pathology of arterial occlusive diseases].
    Beneke G
    Verh Dtsch Ges Kreislaufforsch; 1974; 40():74-94. PubMed ID: 4450702
    [No Abstract]   [Full Text] [Related]  

  • 30. [An outpatient contingent of patients with chronic arterial obliterating diseases of the extremities].
    Koshkin VM; Bogdanets LI; Khaev SKh; Dibirov AD
    Ter Arkh; 1993; 65(1):55-6. PubMed ID: 8036575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Ozone therapy, a new method of treating chronic obliterating arteriopathies].
    Ionescu G; Pitea P; Blaj A
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1985; 34(3):207-13. PubMed ID: 2931752
    [No Abstract]   [Full Text] [Related]  

  • 32. [Etiology and pathogenesis of peripheral obstructive arterial diseases].
    Nitsche W
    Med Welt; 1972 Sep; 23(39):1325-9. PubMed ID: 4639571
    [No Abstract]   [Full Text] [Related]  

  • 33. [Role of several risk factors in chronic obliterating arteriopathies of the extremities].
    Stăncioiu N
    Med Interna (Bucur); 1971 Dec; 23(12):1415-26. PubMed ID: 5159278
    [No Abstract]   [Full Text] [Related]  

  • 34. Prevalence of lower limb occlusive vascular disease in outclinic diabetic patients.
    Andrade JL; Schlaad SW; Koury Junior A; Van Bellen B
    Int Angiol; 2004 Jun; 23(2):134-8. PubMed ID: 15507890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [On the therapeutic activity of hemaseril in treatment of ischemic arteriopathies and phlebopathies].
    Tattoni G; Bigazzi P; Gritta G
    Clin Ter; 1974 Mar; 69(3):225-39. PubMed ID: 4846656
    [No Abstract]   [Full Text] [Related]  

  • 36. [Epidemiology of chronic obstructive arterial disease of the lower limbs and diabetic patients at the University Hospital of Cotonou (Benin)].
    Houénassi M; Sacca-Véhounkpe J; Tchabi Y; Amoussou-Guénou D; Djrolo F; Dossou-Yovo RA; Abattan S; Agboton H
    Arch Mal Coeur Vaiss; 2004 Dec; 97(12):1189-94. PubMed ID: 15669359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [On cutaneous sensitivity to tobacco smoke in chronic peripheral arteriopathies].
    Brassai Z; Horváth E; Spak L; Papp J; Csögör I; Ferencz L
    Med Interna (Bucur); 1973 Nov; 25(11):1385-92. PubMed ID: 4793901
    [No Abstract]   [Full Text] [Related]  

  • 38. Analysis of traditional and nontraditional risk factors for peripheral arterial disease in elderly type 2 diabetic patients in Taiwan.
    Chou CK; Weng SW; Chang HW; Chen CY; Su SC; Liu RT
    Diabetes Res Clin Pract; 2008 Sep; 81(3):331-7. PubMed ID: 18639951
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prevalence of arteriopathies in old age].
    McCook Martínez J; Castellanos Gutiérrez R; Lima Santana B; López Maranges L; Oliú Torres O; Rodríguez Moral N; O'Reilly Sotomayor R
    Angiologia; 1983; 35(4):189-94. PubMed ID: 6614581
    [No Abstract]   [Full Text] [Related]  

  • 40. [Contribution to the study of internal temperatures in subjects with arterial diseases with obliterating evolution. II. Effects of venous administration of papaverine hydrochloride].
    Blasi A; Licciardello M
    Boll Soc Ital Cardiol; 1966; 11(4):1116-9. PubMed ID: 5992025
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.